Abstract
gene knockdowns during Cas9-initiated HDR from a double strand plasmid donor. We find that templated 23 dsDonor repair pathways are mostly genetically distinct from single strand donor DNA (ssDonor) repair 24 but share aspects that include dependency upon the Fanconi Anemia (FA) pathway. We also identified 25 several factors whose knockdown increases HDR and thus act as repressors of gene modification. 26
Screening available small molecule inhibitors of these repressors revealed that the cell division cycle 7-27 related protein kinase (CDC7) inhibitor XL413 increases the efficiency of HDR by 2-3 fold in many 28 contexts, including primary T-cells. XL413 stimulates HDR through cell cycle regulation, inducing an 29 early S-phase cell cycle arrest that, to the best of our knowledge, is uncharacterized for Cas9-induced 30 HDR. We anticipate that XL413 and other such rationally developed inhibitors will be useful tools for 31 boosting the efficiency of gene modification. 32
33

Main Text
34
Genome editing with targeted nucleases, such as CRISPR-Cas9, is a powerful tool for research and a 35 promising approach for therapeutic treatment of human disease. One strategy for efficient genome editing 36 in eukaryotic cells introduces a ribonucleotide protein (RNP) complex comprised of the type II 37 endonuclease Cas9 and a guide RNA (gRNA), which create a double strand DNA break (DSB) at a 38 targeted location in the genome 1,2 . This DSB is repaired by cellular DNA repair pathways to produce two 39 outcomes: error-prone sequence disruption by insertion or deletion (indels) at the DSB, or precise 40 sequence modification via homology directed repair (HDR) that copies a homologous donor DNA into 41 the DSB. The targeted incorporation of introduced DNA sequences enables ground-breaking researchapproaches, including endogenous epitope tagging and the insertion of SNPs to test disease causation, and 43 use of these techniques in human cells promises therapeutics to correct genetic lesions that drive human 44 disease 3, 4 . Strategies to favor precise HDR outcomes over deleterious error-prone repair in human cells 45 are therefore of intense interest both to improve understanding of biological pathways and enable new 46 therapeutic options. 47
48
Human cells have multiple overlapping DSB repair pathways, such as alternative-End Joining (alt-49 EJ), synthesis-dependent strand annealing (SDSA), and homology-directed repair, that have been 50 implicated in Cas9-mediated gene modification [5] [6] [7] . To investigate these mechanisms in greater detail, we 51 previously developed a reporter assay that allowed us to interrogate the genetic requirements of Cas9-52 mediated HDR using single stranded donor DNA (ssDonor) and discovered that single strand template 53 repair (SSTR) requires the Fanconi Anemia (FA) DNA repair pathway 8 . We furthermore found that while 54 HDR from a double stranded DNA plasmid (dsDonor) depends on Rad51, SSTR does not. These distinct 55 requirements for HDR from ssDonor and dsDonor implied that different donors produce molecularly 56 identical gene modifications via different mechanistic routes. To more completely map how different 57 types of donors mediate Cas9-induced HDR, we used genetic screening to reveal the DNA repair factors 58 that are involved in HDR using dsDonor DNA (a subset of HDR, from here on termed HR). Here, we 59 DNA template. The basis of this platform is the stable expression of three components in each cell: 1) a 69 dCas9-KRAB CRISPRi construct 9 , 2) a BFP reporter gene, and 3) a guide RNA targeting the transcription 70 start site (TSS) of a single gene. We constructed a guide RNA library to target genes with Gene Ontology 71 (GO) terms related to DNA metabolism, comprising a library of approximately 2,000 genes at a density 72 of five guides per TSS 10 [Document S1 GUIDES]. Pooled K562 erythroleukemia cell populations stably 73 expressing BFP and individually inhibiting a specific DNA metabolism gene were transiently 74 nucleofected with a Cas9 RNP targeted to introduce a DSB in the BFP reporter, together with a plasmid 75 donor DNA encoding a GFP sequence template that will convert BFP to GFP upon successful HR We identified genes involved in HR by comparing guide RNA frequencies in the GFP + population 84 (i.e. cells that had undergone HR) to guide RNA frequencies in the unsorted control population. Guide 85
RNAs targeting genes that restrict HR were enriched in the GFP + population (because their knockdown 86 favors HR), while guide RNAs targeting genes that are required for HR were depleted from the GFP + 87 population [ Figure 1B ]. Our dsDonor screen revealed that the Fanconi Anemia (FA) repair pathway is 88 required for HR, which is similar to the requirement of the FA pathway for Cas9-mediated SSTR 8 . Thirty 89 one of forty FA and FA-related genes were required for HR, suggesting that this is an activity of the overall 90 FA pathway [ Figure 2A ]. While the FA pathway is typically associated with interstrand crosslink repair 91 and restarting stalled replication forks, our work and those of other labs has consistently indicated that 92 multiple FA genes play a strong role in HDR from multiple types of DNA templates 12 . While most of the 93 such as the FA E2 ubiquitin ligase, UBE2T, or the DNA binding protein, FAAP24. Moreover, components 95 of the FA core complex including FANCA, FANCE, and FANCF showed different magnitudes of 96 phenotypes in each screen. These results imply donor-specific functions for FA sub-complexes [ Figure  97 
2A]. 98
The shared reliance of Cas9-induced SSTR and HR on the FA pathway motivated us to 99 systematically explore overlapping genetic dependencies behind these two activities. We curated lists of 100 statistically significant (p<0.05) genes appearing in the SSTR and HR screens and performed GO term 101 analysis to define pathways involved in each process 13 . There was substantial overlap between SSTR and 102 HR: both pathways require Fanconi Anemia Repair, Nucleotide Excision Repair (NER), and Strand 103 Displacement activities, which is driven by mutual reliance on FA proteins, members of the TFIIH 104 complex, and the BLM helicase. Shared reliance on these pathways implies that both forms of HDR may 105 challenge cells to balance NER-like single strand editing activities and templated repair events, as has 106 been suggested for repair of interstrand crosslinks 14 . Despite these similarities, SSTR and HR are distinct 107 in notable ways. SSTR but not HR depends on "Negative regulation of transposition", a GO term 108 comprising APOBEC3C, D, F, and G. Originally reported as RNA editing enzymes, these enzymes are 109 known to modify single stranded DNA during gene editing reactions 15 , and similar proteins have been 110 repurposed as targeted DNA base-editing reagents 16 . Genes uniquely important for HR, on the other hand, 111
were annotated as "Double Strand Break Repair via Homologous Recombination", because these genes 112 are known to play roles in well-studied forms of dsDonor-templated repair, such as meiotic homologous 113 recombination [ Figure 2B ]. These observations suggest that HDR generally requires the FA pathway, but 114 HR and SSTR require specialized activities to respond to donor topologies or intermediate structures 115
specific to each repair process. 116
We also found several sets of genes that repress HR, and whose knockdown enhances HR 117 efficiency [ Figure 1B] . Some of these genes are consistent with a model in which NHEJ and HR compete 118 to repair DSBs, and that inhibition of one pathway may favor the other [17] [18] [19] . Examples of these repressorgenes include TP53-binding protein 1 (53BP1), X-ray repair cross-complementing protein 4 (XRCC4) 120 and non-homologous end joining factor 1 (NHEJ1), which interact at DSBs to promote DNA ligase 4 121 (LIG4) association during non-homologous end-joining (NHEJ) 20 . Figure 3A] . BFP-to-GFP HDR outcomes were monitored by flow 141 cytometry after four days. We found that cells treated with the CDC7 inhibitor XL413 22 showed a 142 significant increase in both SSTR and HR [ Figure 3B ]. Inhibition of mitogen-activated protein kinase 14 143 (MAPK14) with SB220025 slightly enhanced SSTR and inhibition of PLK3 with GW843682X increasedboth SSTR and HR from a dsDonor, but the effect size was small. All other compounds resulted in no 145 change or even a reduction of HR, which could be caused by impaired cell fitness. siRNA inhibition of 146 CDC7 was less effective than small molecule inhibition [Extended Data Figure 1B ] at promoting HDR, 147 which suggests that inactivating CDC7 kinase may be more effective as an HDR stimulant than reducing 148 the levels of CDC7 kinase. The effect of XL413 is concentration dependent, as both SSTR and HR 149 increased in a dose-dependent manner, with 33 µM XL413 increasing HDR 2-to 3-fold [ Figure 3C ]. 150 Importantly, XL413 concentrations up to 33 µM and exposure for up to 24h did not result in a notable 151 decrease in viability in K562 cells [Extended Data Figure 2A-B] . 152
CDC7 inhibition increases HDR at endogenous loci 153
We next asked if XL413's ability to stimulate HDR is generally applicable to multiple genomic 154 loci, cell types, and HDR "cargo" sizes. We used Cas9-induced HR to knock-in a plasmid dsDonor GFP 155 coding sequence at the C-terminus of three different genes: lysosomal-associated membrane protein 1 156 (LAMP1), fibrillarin (FBL) and translocase of outer mitochondrial membrane 20 (TOMM20). These 157 knock-in reagents were previously developed as part of a comprehensive cell-tagging effort in induced 158 pluripotent stem cells (iPSCs) 23 . We found that treatment with XL413 for 24 hours directly after 159 nucleofection increased the HR efficiency at LAMP1, FBL and TOMM20 by two-to three-fold, 160 irrespective of the original frequency of HR [ Figure 4A ]. Furthermore, we tested XL413 at the LAMP1 161 locus in HCT116 and HeLa cell lines and found that these cell lines also significantly increased HR to a 162 similar extent [ Figure 4B ]. These data demonstrate that the XL413 CDC7 inhibitor increases HR 163 independently of the genomic locus and cell type and can be used for the installation of long sequences 164 via HR. 165
We investigated if SSTR is similarly increased by CDC7 inhibition at an endogenous locus. We 166 designed an editing strategy that uses an ssDonor to insert a 2xFLAG tag and linker at the C-terminus of 167 TOMM20 [ Figure 4C ]. To avoid re-cutting the repaired locus, we introduced three additional silent 168 substitutions into the donor template to remove the gRNA recognition site. A hallmark of SSTR is a strongdecrease in donor sequence incorporation with increasing distance from the Cas9-cut site 24 . However, 170 sometimes PAM sites are unavailable at the exact introduction site reducing knock-in efficiencies 171 dramatically. Increasing SSTR efficiency in such a context would be particularly helpful. We incorporated 172 this scenario into our experiments by designing the ssDonor so that the tag insertion is 20 bp from the 173 Cas9 cut site. Using amplicon PCR and next-generation sequencing, we found that XL413-treated cells 174 again had a two-to three-fold increase in SSTR relative to untreated cells, significantly boosting the 175 insertion of the FLAG-tag, despite its distance from the Cas9-cut site [ Figure 4D ]. Sequence-level 176 increases in tag insertion corresponded to increased ability to detect FLAG-tagged TOMM20 by Western 177 blotting [ Figure 4E ]. These findings suggest that CDC7 inhibition robustly increases SSTR and HR, and 178 in this context can be used to increase the frequency of both single nucleotide substitutions and 179 endogenous gene tagging. 180
181
CDC7 inhibition enhances knock-in efficiency in primary T-cells 182
HDR in primary cells is a long-standing goal of gene editing, both for its ability to correct disease-183 causing SNPs and to deliver large payloads such as chimeric antigen receptors 21, 25 . We therefore 184 investigated the ability of XL413 to increase HR in human T-cells derived from healthy donor peripheral 185 blood mononuclear cells (PBMCs). We performed editing using an RNP targeting the RAB11A locus and 186 a linear dsDNA donor to generate an N-terminal GFP fusion 21 . XL413 treatment after editing produced a 187 dose-dependent increase in HR efficiency that approached two-fold over the untreated control [ Figure  188 
CDC7 inhibition causes cell cycle arrest
We next examined the molecular mechanism by which the XL413 CDC7 inhibitor leads to 195 increased HDR. CDC7 is the catalytically active subunit of DBF4-dependent kinase (DDK), which 196 phosphorylates and activates the MCM helicase to initiate the G1/S transition 26, 27 . We therefore expected 197 XL413 to halt cells in G1/S instead of late S/G2 when HR is supposed to be most active. We found that 198 XL413 treatment indeed rapidly and reversibly inhibited MCM2 phosphorylation [ Figure 5A ], but that 199 
Timing of CDC7 inhibition determines its efficacy 205
Since CDC7 is an initiator of the G1/S transition, we reasoned that even a slight alteration of the 206 timing of XL413 administration should dramatically alter cell cycle distribution. We previously arrested 207 cells using a timing that would cause them to accumulate in G1/S during editing by "post" exposure to 208 CDC7 inhibitor (e.g. edited cells recovered into XL413-containing medium) [ Figure 4 ]. We therefore 209 asked whether accumulating cells in G1/S and then releasing them during editing by "pre" exposure to 210 XL413 would move them from an HR permissive to non-permissive section of the cell cycle. 211
212
Our usual post-exposure to XL413 after RNP and donor nucleofection supported increased levels 213 of SSTR and HR [ Figure 6A ]. However, pre-exposure to XL413 and then release during editing resulted 214 in reduced levels of HDR, suggesting that timing of cell cycle arrest and releasing the cells into HDR-215 permissive S-phase is crucial. The cell cycle arrest caused by XL413 presumably changes three major 216 parameters in the cell: the activity of CDC7, the frequency of replication fork-DSB encounters, and the 217 activation of cell-cycle regulated DNA repair pathways 29 . While Aphidicolin and Hydroxyurea also 218 arrested cells at the G1/S transition, these arrests preserved a G1 DNA content [ Figure 5C -D], and did 219 not support increased HR across multiple sites when used with the same drug-administration scheme as 220 XL413 (i.e. edit, recover into drug, then transfer to drug-free media) [ Figure 6B ]. Together with our pre-221 vs post-inhibition experiments, this suggests that early-to-mid S-phase is a critical window for Cas9-222 mediated SSTR and HR, rather than the assumed late S/G2. 223 224 Finally, we asked how CDC7 inhibition by XL413 compared to other small molecule approaches that 225 have been reported to boost HR and SSTR. The LIG4 inhibitor SCR7 reportedly increases HR by 226 inhibiting NHEJ, and the RAD51 agonist RS-1 reportedly increases HR by boosting recombination 227 itself 30, 31 . We tested both SCR7 and RS-1 for their ability to increase HR and SSTR at two different 228 ties between screen and validation may thus be the basis for future screening approaches using these 269
reagents. 270
We shown as mean±SD (n=3 biological replicates). Statistical significances were calculated by unpaired t-test 381 (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s.: not significant). 382 for 60 sec, and one cycle of 72°C for 4 min, and held at 4°C. PCR amplicons were purified using SPRI 510 beads, run on a 1.5% agarose gel to verify size and purity, and quantified by Qubit (Thermo Fisher, 511
Waltham, MA). 512
NGS Library Generation and Sequencing 514
Illumina adaptors and index sequences were added to 100ng of purified PCR amplicons by amplify-on 515 PCR. Amplify-on was performed using 100ng of template DNA, 0.5 µM of forward/reverse primers, and 516 2x Q5 Master Mix (NEB). The thermocycler was set for one cycle of 98°C for 30 seconds, 16 cycles of 517 98°C for 10 sec, 62°C for 20 sec, 72°C for 30 sec, and one cycle of 72°C for 1 min, and held at 4°C. Each 518 adaptor-conjugated amplicon was quantified by qubit, normalized, and pooled at equimolar amounts. 519
Pooled samples were purified using SPRI beads. Library size and purity was verified by Bioanalyzer trace 520 prior to sequencing on an Illumina MiSeq using reagent kit v3 (2x300bp). 521
NGS Analysis of Amplicons 523
Samples were deep sequenced on an Illumina MiSeq at 300bp paired-end reads to a depth of at least 524 Briefly, reads were adapter trimmed then joined before performing a global alignment between reads and 526 the reference and donor sequences using NEEDLE 39 . Rates of HDR are calculated as total number of 527 reads that are successfully converted to the donor sequence (and have no insertions or deletions at the 528 cutsite) divided by the total number of aligned reads. NHEJ rates are calculated as any reads where an 529 insertion or deletion overlaps the cutsite or occurs within a six basepair window around the cutsite divided 530 by the total number of aligned reads. SSTR/HDR rates were calculated at specific regions by counting 531 total number of reads with flag occurrence divided by the number of aligned reads. were sorted into GFP+ (GFP) and non-fluorescent (NON) populations on a Sony SH800S sorter. In 545 parallel, an 85e+06 cell aliquot was harvested from each non-electroporated population the day of the sort 546 (UNZAP), and an 85e+06 cell aliquot was harvested from each nucleofected cell library on the day of 547 sorting (PRESORT). Harvested and sorted populations were spun down, rinsed in PBS, and frozen at -548 80°C. 549 550 DNA from each cell population: PREZAP, UNZAP, PRESORT, GFP, and NON (non-treated) was 551 purified using Machery-Nagel Blood Purification kits and the total amount of DNA quantified. One 552 microgram of genomic DNA was amplified per Phusion HiFi PCR reaction using primers specific to the 553 gRNA cassette as described 40 . Up to 24 PCR reactions were set up for each cell population to obtain 554 desired coverage of the cell library. The thermocycler was set for one cycle of 98°C for 30 sec, 25 cycles 555 of 98°C for 15 sec, 56°C for 15 sec, and 72°C for 15 sec, and one cycle of 72°C for 10 min and held at 556 4°C. PCR reactions were pooled, purified using SPRI beads, and sized on an agarose gel. Amplified DNA 557 from each cell population was normalized to input cell numbers, purified a second time using SPRI beads, 558 and sequenced on a HiSeq2500 (Illumina). at 2 mM, SRC7 at 1 µM, RS1 at 10 µM, Aphidicolin at 2 µg/mL, A64 trifluoroacetate at 1 µM, SB220025 597 at 0.5 µM, GKT136901 at 50 µM, GW843682X at 0.5 µM, Ro3280 at 100 nM, and UNC2170 598 trifluoroacetate at 150 µM. Cells were drug treated for 24 hours, harvested, washed, and recovered into 599 fresh media. Cells were harvested for flow cytometry or amplicon sequencing 4 days post nucleofection. 600 601 qPCRBetween 1e+05 and 2e+05 cells were harvested and RNA extracted using Qiagen RNeasy kits (Qiagen, 603 Venlo, Netherlands). cDNA was produced from 1 µg of purified RNA using the iScript Reverse 604
Transcription Supermix (Bio-Rad). qPCR reactions were performed using the SsoAdvanced Universal 605 SYBR Green Supermix (Bio-Rad) in a total volume of 10 µl with primers at final concentrations of 500 606 nM. The thermocycler was set for 95°C for 2 mins and 40 cycles of 95°C for 2 sec and 55°C for 8 sec. 607
Fold enrichment of the assayed genes over the control ACT1B and/or GAPDH loci were calculated using 608 the 2 -ΔΔCt method essentially as described 41 . Primer sequences can be found in Document S1. 
